Inventor
STAPPER CHRISTIAN
DE13 patents
⚠️ This page may combine multiple inventors who share the name “STAPPER CHRISTIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI AVENTIS DEUTSCHLAND
10 patentsUS7335671B2Feb 26, 2008
Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND9 citations83
US7160911B2Jan 9, 2007
Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND14 citations83
US7148246B2Dec 12, 2006
Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND18 citations83
US7259177B2Aug 21, 2007
Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND3 citations62
US7872034B2Jan 18, 2011
Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7365084B2Apr 29, 2008
Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7956077B2Jun 7, 2011
2-{-3,′2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes
SANOFI AVENTIS DEUTSCHLAND0 citations50
US7220876B2May 22, 2007
Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals
SANOFI AVENTIS DEUTSCHLAND0 citations41
US7598281B2Oct 6, 2009
Arylcycloakyl-substituted alkanoic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes
SANOFI AVENTIS DEUTSCHLAND0 citations39
US7538131B2May 26, 2009
2-{-3-′2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes
SANOFI AVENTIS DEUTSCHLAND0 citations39